Author

Munera Alghanim

UTSW - Dallas, UNTHSC - Fort Worth, CDRI - India - Cited by 3,230

Biography

 Munera Alghanim works at the Immunology and Innovative Cell Therapy from Dasman Diabetes Institute (DDI), Kuwait. Recently she published an article in the Journal of Glycomics & Lipidomics. He is a professor in University, has more than 10 years of experience in Research & Teaching, has expertise in related field, characterization, structural analysis, Targeted lipidomics analysis, Biological Sciences and life sciences. His research also include broad range of analysis.
Title
Cited by
Year
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis
D Adams, A Gonzalez-Duarte, WD O’Riordan, CC Yang, M Ueda, ...New England Journal of Medicine 379 (1), 11-21, 2018201
1970
2018
Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study
SD Solomon, D Adams, A Kristen, M Grogan, A González-Duarte, ...Circulation 139 (4), 431-443, 2019201
351
2019
Targeting of antithrombin in hemophilia A or B with RNAi therapy
KJ Pasi, S Rangarajan, P Georgiev, T Mant, MD Creagh, T Lissitchkov, ...New England Journal of Medicine 377 (9), 819-828, 2017201
347
2017
Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model
P Dohare, P Garg, U Sharma, NR Jagannathan, M RayBMC complementary and alternative medicine 8, 1-20, 2008200
114
2008
Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat
P Dohare, P Garg, V Jain, C Nath, M RayBehavioural brain research 193 (2), 289-297, 2008200
109
2008
Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke
P Garg, RS Duncan, S Kaja, P KoulenNeuroscience 166 (1), 252-262, 2010201
58
2010
The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders
L Prokai, V Nguyen, S Szarka, P Garg, G Sabnis, HA Bimonte-Nelson, ...Science Translational Medicine 7 (297), 297ra113-297ra113, 2015201
53
2015
Amino acid-based enantiomerically pure 3-substituted 1, 4-benzodiazepin-2-ones: A new class of anti-ischemic agents
JK Mishra, P Garg, P Dohare, A Kumar, MI Siddiqi, M Ray, G PandaBioorganic & medicinal chemistry letters 17 (5), 1326-1331, 2007200
52
2007
Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke
P Garg, RS Duncan, S Kaja, A Zabaneh, KD Chapman, P KoulenNeuroscience letters 492 (3), 134-138, 2011201
32
2011
The neuronal apoptotic death in global cerebral ischemia in gerbil: important role for sodium channel modulator
MK Brahma, P Dohare, S Varma, SK Rath, P Garg, PK Biswal, ...Journal of neuroscience research 87 (6), 1400-1411, 2009200
23
2009
Endovascular treatment of infrainguinal chronic total occlusions using the TruePath device: features, handling, and 6-month outcomes
S Banerjee, K Sarode, T Das, O Hadidi, R Thomas, A Vinas, P Garg, ...Journal of Endovascular Therapy 21 (2), 281-288, 2014201
22
2014
A subcutaneously administered investigational RNAi therapeutic (ALN-CC5) targeting complement C5 for treatment of PNH and complement-mediated diseases: interim phase 1 study …
A Hill, J Taubel, J Bush, A Borodovsky, N Kawahata, H Mclean, C Powell, ...Blood 126 (23), 2413, 2015201
19
2015
Significance of an abnormal ankle-brachial index in patients with established coronary artery disease with and without associated diabetes mellitus
S Banerjee, A Vinas, A Mohammad, O Hadidi, R Thomas, K Sarode, ...The American Journal of Cardiology 113 (8), 1280-1284, 2014201
18
2014
Changes in N-acylethanolamine pathway related metabolites in a rat model of cerebral ischemia/reperfusion
A Kilaru, P Tamura, P Garg, G Isaac, D Baxter, RS Duncan, R Welti, ...Journal of glycomics & lipidomics 1 (1), 2011201
17
2011
Low-density lipoprotein cholesterol: how low can we go?
DP Sherbet, P Garg, ES Brilakis, S BanerjeeAmerican Journal of Cardiovascular Drugs 13, 225-232, 2013201
15
2013
A subcutaneously administered investigational RNAi therapeutic (ALN-AT3) targeting antithrombin for treatment of hemophilia: interim phase 1 study results in patients with …
B Sorensen, T Mant, P Georgiev, S Rangarajan, JK Pasi, D Creagh, ...Journal of Thrombosis and Haemostasis 13, 176-177, 2015201
10
2015
Blunt microdissection for endovascular treatment of infralinguinal chronic total occlusions.
S Banerjee, O Hadidi, A Mohammad, A Alsamarah, R Thomas, K Sarode, ...Journal of Endovascular Therapy 21 (1), 71-78, 2014201
9
2014
Methods and compositions for treating a Serpinc1-associated disorder
A Akinc, B Sorensen, P Garg, G RobbieUS Patent 11,091,759, 2021202
3
2021
Eosinophilic meningitis.
FJ Heldrich, PP GargMaryland Medical Journal (Baltimore, Md.: 1985) 7 (2), 18-140, 1988198
3
1988
Transient 5‐(4‐phenylbutoxy) psoralen (PAP‐1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles
ME Stokely, P Garg, MA Bhat, P KoulenJournal of neuroscience research 86 (9), 111-14, 00800
2
2008

Referred From: https://scholar.google.com/citations?user=3bDkdGoAAAAJ&hl=en

Cited by
Citations 3230
h-index 15
i10-index 16
Recommended Journals
Open Access Journals